Reuters logo
BRIEF-Hangzhou Tianmushan Pharmaceutical Enterprise receives acquisition compensation
October 9, 2017 / 3:37 AM / 2 months ago

BRIEF-Hangzhou Tianmushan Pharmaceutical Enterprise receives acquisition compensation

Oct 9 (Reuters) - Hangzhou Tianmushan Pharmaceutical Enterprise Co Ltd :

* Says it received land and buildings acquisition compensation of 17.2 million yuan

Source text in Chinese: goo.gl/DWnvTL

Further company coverage: (Beijing Headline News)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below